1. Home
  2. EXFY vs MDWD Comparison

EXFY vs MDWD Comparison

Compare EXFY & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXFY
  • MDWD
  • Stock Information
  • Founded
  • EXFY 2008
  • MDWD 2000
  • Country
  • EXFY United States
  • MDWD Israel
  • Employees
  • EXFY N/A
  • MDWD N/A
  • Industry
  • EXFY Computer Software: Prepackaged Software
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • EXFY Technology
  • MDWD Health Care
  • Exchange
  • EXFY Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • EXFY 165.4M
  • MDWD 195.2M
  • IPO Year
  • EXFY 2021
  • MDWD 2014
  • Fundamental
  • Price
  • EXFY $1.63
  • MDWD $18.80
  • Analyst Decision
  • EXFY Strong Buy
  • MDWD Strong Buy
  • Analyst Count
  • EXFY 3
  • MDWD 2
  • Target Price
  • EXFY $4.75
  • MDWD $35.00
  • AVG Volume (30 Days)
  • EXFY 481.5K
  • MDWD 85.2K
  • Earning Date
  • EXFY 11-06-2025
  • MDWD 11-25-2025
  • Dividend Yield
  • EXFY N/A
  • MDWD N/A
  • EPS Growth
  • EXFY N/A
  • MDWD N/A
  • EPS
  • EXFY N/A
  • MDWD N/A
  • Revenue
  • EXFY $144,251,000.00
  • MDWD $19,858,000.00
  • Revenue This Year
  • EXFY $5.45
  • MDWD $21.39
  • Revenue Next Year
  • EXFY $2.56
  • MDWD $23.01
  • P/E Ratio
  • EXFY N/A
  • MDWD N/A
  • Revenue Growth
  • EXFY 4.13
  • MDWD N/A
  • 52 Week Low
  • EXFY $1.60
  • MDWD $14.14
  • 52 Week High
  • EXFY $4.13
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • EXFY 34.67
  • MDWD 57.23
  • Support Level
  • EXFY $1.63
  • MDWD $17.72
  • Resistance Level
  • EXFY $1.75
  • MDWD $19.88
  • Average True Range (ATR)
  • EXFY 0.07
  • MDWD 0.64
  • MACD
  • EXFY -0.01
  • MDWD 0.18
  • Stochastic Oscillator
  • EXFY 3.23
  • MDWD 61.77

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: